Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 6

Impact of PPIs on patient focused symptomatology in GERD

Authors ABR Thomson

Published 5 December 2008 Volume 2008:4(6) Pages 1185—1200

DOI https://doi.org/10.2147/TCRM.S3132

Review by Single-blind

Peer reviewer comments 3

ABR Thomson

Division of Internal Medicine, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada

Abstract: About half of patients with gastroesophageal reflux disease (GERD) have a normal endoscopy, so symptom assessment is the only appropriate outcome measure for these persons. Symptom assessment is also of great importance in persons with erosive esophagitis. There is currently no fully validated questionnaire to compare symptom response to treatment of patients with GERD. The aim of this review is to consider ReQuest™ assessment tool to evaluate esophageal, supra-esophageal, and infra-esophageal symptoms, as well as any modification of the patient’s quality of life. The ReQuest™ may be combined with the Los Angeles classification of esophagitis (LA A-D), to include the normal endoscopic finding in normal endoscopy reflux disease. The ReQuest™ score declines rapidly towards normal with patient treatment with a proton pump inhibitor. A proportion of patients need more than the usual 8 weeks of therapy. For example, in GERD patients with Los Angeles B-D, the ReQuest™ score falls more with pantoprazole 40 mg than with esomoprazole 40 mg after 12 weeks of therapy. Now that the simplified ReQuest in Practice™ is available, this validated brief questionnaire has potential as an instrument for use in GERD patients seen in everyday clinical practice.

Keywords: complete healing, dyspepsia, erosive esophagitis, GERD symptoms, pH, ReQuest™

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report

Noda Y, Daskalakis ZJ, Downar J, Croarkin PE, Fitzgerald PB, Blumberger DM

Neuropsychiatric Disease and Treatment 2014, 10:2049-2055

Published Date: 31 October 2014

Hospitalization rate and 30-day mortality among patients with status asthmaticus in Denmark: a 16-year nationwide population-based cohort study

Strid JM, Gammelager H, Johansen MB, Tønnesen E, Christiansen CF

Clinical Epidemiology 2013, 5:345-355

Published Date: 5 September 2013

Pleural effusion: diagnosis, treatment, and management

Karkhanis VS, Joshi JM

Open Access Emergency Medicine 2012, 4:31-52

Published Date: 25 June 2012

Existing data sources for clinical epidemiology: the Danish National Pathology Registry and Data Bank

Rune Erichsen, Timothy L Lash, Stephen J Hamilton-Dutoit, et al

Clinical Epidemiology 2010, 2:51-56

Published Date: 30 March 2010

Two-step LASIK after penetrating keratoplasty

Aris N Kollias, Markus M Schaumberger, Thomas C Kreutzer, et al

Clinical Ophthalmology 2009, 3:581-586

Published Date: 20 October 2009

Sevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis

Vincenzo Savica, Domenico Santoro, Paolo Monardo, Agostino Mallamace, Guido Bellinghieri

Therapeutics and Clinical Risk Management 2008, 4:821-826

Published Date: 8 August 2008